Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Cabell currently holds 676,564 shares of ARENA PHARMACEUTICALS INC (ARNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Cabell has been a net seller of ARNA stock. They have purchased $0 and sold $884.0K worth of shares.
Christopher Cabell's most recent insider trade was on Feb 21, 2026, when they sold 338,282 shares at $0.00 per share.
Christopher Cabell serves as Executive at ARENA PHARMACEUTICALS INC (ARNA). They have executed 7 insider transactions totaling $884.0K over their tenure at the company.
Christopher Cabell holds the position of Executive at ARENA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Christopher Cabell has shown a selling trading pattern, with $0 in total purchases and $884.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Cabell was on Jul 15, 2020, when they sold $884.0K worth of ARNA shares. This transaction involved 13,000 shares at $68.00 per share.
Christopher Cabell currently owns 676,564 shares of ARENA PHARMACEUTICALS INC (ARNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Cabell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Cabell has 7 Form 4 filings on record as an insider at ARENA PHARMACEUTICALS INC.
Set alerts for Christopher Cabell and 40,000+ other insiders.